Detalhe da pesquisa
1.
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.
BMC Cancer
; 18(1): 194, 2018 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29454321
2.
Detection of drug safety signals from clinical trials data: Role of SUSARs.
Pharmacol Res
; 131: 218-223, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29444478
3.
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
Br J Cancer
; 113(4): 585-94, 2015 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26171933
4.
Impact of Medication Reconciliation in Oncology Early Phase Studies: A Drug-Drug Interaction Retrospective Study.
JCO Oncol Pract
; 20(3): 386-392, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944082
5.
French national survey on breast cancer care: caregiver and patient views.
Breast Cancer
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635135
6.
[Comparative costs study between ready-to-administer bag of gemcitabine and production in reconstitution unit]. / Étude comparative de coûts entre les poches de gemcitabine prêtes à l'emploi et une fabrication en unité de reconstitution.
Bull Cancer
; 105(7-8): 679-685, 2018.
Artigo
em Francês
| MEDLINE | ID: mdl-29958654
7.
"Metronomic" chemotherapy in advanced soft tissue sarcomas.
Cancer Chemother Pharmacol
; 66(1): 197-202, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20182726
8.
MAP1A light chain-2 interacts with GTP-RhoB to control epidermal growth factor (EGF)-dependent EGF receptor signaling.
J Biol Chem
; 283(7): 4155-64, 2008 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056259